Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-blocking agents and human fat cell adenylate cyclase.

H Kather, B Simon

    Research Communications in Chemical Pathology and Pharmacology
    |September 1, 1977
    PubMed
    Summary

    Beta-blocking drugs inhibit human adenylate cyclase. Non-selective beta-blockers are more potent inhibitors than cardioselective agents, impacting cyclic AMP (cAMP) formation in fat cells.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic histological and immune markers of renal cell carcinoma.

    Pathology oncology research : POR·2001
    Same author

    Synthesis of ganglioside GD3 and its comparison with bovine GD3 with regard to oligodendrocyte apoptosis mitochondrial damage.

    Chemistry (Weinheim an der Bergstrasse, Germany)·2001
    Same author

    Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.

    Alcoholism, clinical and experimental research·2001
    Same author

    [Prof. Bernd Simon on nonsteroidal anti-inflammatory drugs. Gastrointestinal complications are unpredictable].

    MMW Fortschritte der Medizin·2001
    Same author

    Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania.

    The American journal of tropical medicine and hygiene·2001
    Same author

    Epidemiological trends in pancreatic neoplasias.

    Digestive diseases (Basel, Switzerland)·2001

    Area of Science:

    • Biochemistry
    • Pharmacology

    Background:

    • Adenylate cyclase is a key enzyme in cellular signaling pathways.
    • Beta-adrenergic receptors modulate adenylate cyclase activity through catecholamines.

    Purpose of the Study:

    • To investigate the inhibitory effects of various beta-blocking agents on catecholamine-activated adenylate cyclase in human fat cell ghosts.
    • To compare the potency of non-selective and cardioselective beta-blockers on this enzyme system.

    Main Methods:

    • Preparation of human fat cell ghosts.
    • Assay of isoproterenol-stimulated adenylate cyclase activity.
    • Determination of half-maximal inhibitory concentrations (IC50) for different beta-blockers.

    Main Results:

    • Both non-selective and cardioselective beta-blockers inhibited human adenylate cyclase.
    • Non-selective beta-blockers (e.g., propranolol) showed potent inhibition within a narrow concentration range (5x10^-7 M to 3x10^-6 M).
    • Cardioselective beta-blockers (e.g., atenolol, practolol) were significantly less potent, requiring 100 to 1000 times higher concentrations for half-maximal inhibition.

    Conclusions:

    • Non-selective beta-blocking drugs are more effective inhibitors of human fat cell adenylate cyclase compared to cardioselective agents.
    • The differential potency suggests distinct interactions or efficacies of beta-blocker subclasses on this specific enzyme system.

    Related Experiment Videos